论文部分内容阅读
慢性肺心病急性发作期的患者症状明显加重,这与患者血液为血栓前状态有关,此时患者血液具高黏滞、低抗凝、低纤溶的特点,成为肺内广泛微小动脉血栓形成的基础[1],使缺氧加重、肺动脉压力增高、病情恶化。低分子量肝素钙注射液有降低血液黏滞度,增高纤溶酶活性,扩张肺血管及冠状血管,降低肺动脉高压等作用。本科将此药物用于慢性肺心病急性发作期的治疗,能明显改善机体血栓前状态,报告如下。
Patients with acute episodes of chronic pulmonary heart disease symptoms significantly worse, which is related to the patient’s blood before the prothrombotic state, when the patient’s blood with high viscosity, low anticoagulant, low fibrinolytic characteristics of lung extensive micro-arterial thrombosis Basis [1], so that hypoxia, increased pulmonary artery pressure, the condition deteriorated. Low molecular weight heparin calcium injection can reduce blood viscosity, increase plasmin activity, expansion of pulmonary and coronary vessels, reduce pulmonary hypertension and so on. Undergraduate this medicine for the treatment of acute episodes of chronic pulmonary heart disease, can significantly improve the body’s pre-thrombosis state, the report is as follows.